Send feedback

TP63 p.Ser622Arg

c.1866T>G · VCV4633439

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.7184 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00167%, amr)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.7184likely pathogenic
REVEL0.496indeterminate
SaProtLLR -8.79tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP -4.2GERP -5.6
Regional constrainto/e 0.80unconstrained · MANE · 26 kb · p 4.9e-05 · regional, not allelic
Overall
CADD17.83PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00167% Admixed American · 1/59,988 alleles
Filtering AF 2.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.1e-05%
Overall 0.000186% 3/1,613,890 alleles · very rare exomes 3/1,461,878 · genomes 0/152,012 · joint denominator
Ancestry group Frequency 1 in
Admixed Americangrpmax 0.00167% 59,988
European (non-Finnish) 0.000169% 589,988

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TP63
Protein
p.Ser622Arg
Coding
c.1866T>G
MANE Select
NM_003722
Type
single nucleotide variant
Location
chr3:189894325 (GRCh38)
Gene constraint
LOEUF 0.296 · pLI 1.00 · ClinGen HI 1/3 (gnomAD)
Structure
AlphaFold pLDDT 63.70 · 26 PDB
Residue 622
an α-helix; a UniProt-annotated variant site (in pof21; results in increased transcriptional activation in luciferase reporter assays; affects oligomerization); a UniProt-annotated variant site (in pof21); the 'transactivation inhibition' region
Full TP63 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tp63-p-ser622arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown